Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ximo Pechuan-Jorge

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Nature|May 31, 2023
In situ tumour arrays reveal early environmental control of cancer immunityGuadalupe Ortiz-Muñoz, Markus Brown, Catherine B Carbone, et al.
Cancer Cell|April 24, 2026
Anticancer activity of RAS-GTP inhibition in cholangiocarcinomaRodrigo Entrialgo-Cadierno, Konstantina Morali, Iker Feliu, et al.
Cancer Discovery|July 8, 2024
Mechanisms of Response and Tolerance to Active RAS Inhibition in KRAS-Mutant Non-Small Cell Lung CancerHaniel A Araujo, Ximo Pechuan-Jorge, Teng Zhou, et al.
Cancer Discovery|February 11, 2026
Abrogation of Oncogenic RAS Signaling by a RAS(ON) Inhibitor Doublet Primes Immune-refractory KRAS G12C-mutant NSCLC for Immune Checkpoint BlockadeXing Wei, Cristina Blaj, M Ali Al-Radhawi, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Nature|May 31, 2023
In situ tumour arrays reveal early environmental control of cancer immunityGuadalupe Ortiz-Muñoz, Markus Brown, Catherine B Carbone, et al.
Cancer Cell|April 24, 2026
Anticancer activity of RAS-GTP inhibition in cholangiocarcinomaRodrigo Entrialgo-Cadierno, Konstantina Morali, Iker Feliu, et al.
Cancer Discovery|July 8, 2024
Mechanisms of Response and Tolerance to Active RAS Inhibition in KRAS-Mutant Non-Small Cell Lung CancerHaniel A Araujo, Ximo Pechuan-Jorge, Teng Zhou, et al.
Cancer Discovery|February 11, 2026
Abrogation of Oncogenic RAS Signaling by a RAS(ON) Inhibitor Doublet Primes Immune-refractory KRAS G12C-mutant NSCLC for Immune Checkpoint BlockadeXing Wei, Cristina Blaj, M Ali Al-Radhawi, et al.
Pageof 2